Studies from Instituto Nacional de Perinatologia Yield New Data on HIV/AIDS Lipodystrophy Syndrome (Impact of Protease Inhibitor-Based Highly Active Antiretroviral Therapy on Fetal Subcutaneous Fat Tissue in HIV-Pregnant Women in a...).

A study conducted by the Instituto Nacional de Perinatologia in Mexico City examined the impact of protease inhibitor-based highly active antiretroviral therapy (PI-HAART) on fetal subcutaneous fat tissue in HIV-pregnant women. The study found that fetuses exposed to PI-HAART exhibited a significant reduction in subcutaneous fat, particularly in the proximal third-middle union of the femur. This reduction was correlated with lower newborn serum glucose levels. The findings highlight the need for a more balanced approach to managing pregnant women with HIV and call for further research on the long-lasting effects of PI-HAART on newborns and children's well-being. [Extracted from the article]

Copyright of AIDS Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)